DNA methylation profiling in MEN1-related pancreatic neuroendocrine tumors reveals a potential epigenetic target for treatmentElfi B. Conemans(University Medical Center Utrecht), Menno R. Vriens(University Medical Center Utrecht)European Journal of EndocrinologyJune 14, 201810.1530/eje-18-0195Cited by 36SaveCiteExport RISWatch citationsRelated PapersEnhancer signatures stratify and predict outcomes of non-functional pancreatic neuroendocrine tumors|Nature Medicine|2019|185Publisher Correction: Enhancer signatures stratify and predict outcomes of non-functional pancreatic neuroendocrine tumors|Nature Medicine|2019|5